Neuropsychiatry and Behavioral Pharmacology

Detalles Bibliográficos
Autor principal: Gualtieri, C. Thomas. (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 1991.
Edición:1st ed. 1991.
Materias:
Acceso en línea:https://doi.org/10.1007/978-1-4613-9036-7
LEADER 04304nam a22003015i 4500
001 978-1-4613-9036-7
005 20191025191043.0
007 cr nn 008mamaa
008 121227s1991 xxu| s |||| 0|eng d
020 |a 9781461390367 
024 7 |a 10.1007/978-1-4613-9036-7  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
100 1 |a Gualtieri, C. Thomas.  |e author. 
245 1 0 |a Neuropsychiatry and Behavioral Pharmacology  |c by C. Thomas Gualtieri. 
250 |a 1st ed. 1991. 
260 # # |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 1991. 
300 |a XII, 353 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a 1. The Neuropsychiatric Sequelae of Traumatic Brain Injury -- The Neurobehavioral Sequelae of Traumatic Brain Injury -- The Prediction of Outcome -- The Trajectory of Recovery -- Evaluation of the TBI Patient -- 2. Delayed Neurobehavioral Sequelae of Traumatic Brain Injury -- Affective Disorders -- Delayed Amnesia -- Posttraumatic Epilepsy -- Psychosis -- Dementia -- 3. The Psychopharmacology of Traumatic Brain Injury -- Principles of Treatment -- Psychostimulants -- Amantadine -- Other Dopamine Agonists -- Antidepressants -- Lithium -- Neuroleptics -- The Psychotropic Anticonvulsants -- Benzodiazepines -- Buspirone -- Beta-Adrenergic Blockers -- Alpha Agonists -- Calcium Channel Blockers -- Opiates -- Other Neuropeptides -- Cholinergic Drugs -- Nootropes -- Cranial Electrostimulation (CES) -- Examining the Patient on Psychoactive Medication -- 4. Inadvertent Drug Effects -- Licit Drugs -- Illicit Drugs -- Drugs Prescribed for Medical Reasons -- H2 Receptor Antagonists -- Sympathomimetics -- Antispasticity Drugs -- 5. Epilepsy -- Neuropsychiatric Conditions in Epileptic Patients -- Psychiatric Conditions That May Be Related to Epilepsy -- Neuropsychological and Behavioral Effects of Anticonvulsant Drugs -- Psychotropic Drugs as Convulsants and as Anticonvulsants -- 6. Neuropsychiatric Disorders in Mentally Retarded People -- Traditional Psychiatric Disorders -- Behavioral Disorders -- Pathobehavioral Mental Retardation Syndrome -- Disorders of Serotonin Regulation -- 7. Self-Injurious Behavior -- The Pharmacotherapy of SIB -- Testing the D1 Model -- The Differential Diagnosis of SIB -- 8. Behavior in the Cornelia De Lange Syndrome -- The CDLS Survey -- Contrasting Data -- Behavior in the Cornelia de Lange Syndrome -- 9. Autism -- What Is Autism? -- The Psychopharmacology of Autism -- Psychopharmacology for Autistic People -- Epilepsy -- Self-Injurious Behavior -- Aggression -- Obsessive-Compulsive Behavior -- Tourette’s Syndrome -- Abulia -- Affective Disorders -- Anxiety, Agitation, and Panic -- Psychosis and Schizophrenia -- Hyperactive or Disorganized Behavior -- The Kluver-Bucy Syndrome -- Megavitamins -- 10. Tardive Dyskinesia -- The Prevalence of Serious Neuroleptic Side Effects -- Risk Factors for Tardive Dyskinesia -- Biological Mechanisms -- Diagnosis -- Treatment -- The Course of the Disorder -- Malignant TD -- Behavioral and Cognitive Manifestations of Tardive Dyskinesia -- Neuroleptic Nonresponders -- Alternatives to Neuroleptic Treatment -- Tardive Dyskinesia Policy and Recommendations -- TMS: A System for Prevention and Control -- The Development of TMS -- 11. Three Neuropsychiatric Conditions of Childhood -- Childhood Hyperactivity -- The Kleine-Levin Syndrome -- Rheumatic Psychosis -- 12. Behavioral Psychopharmacology -- Therapeutic Trials Are Hypothesis Testing -- Theoretical Models Run in Parallel -- Behavior Is a Measurable Thing -- There Is a Personal Economy to Consider -- And a Wider Economy -- Structure -- Epilepsy Is First -- In Fever of Unknown Origin, Stop All Drugs -- Overt Toxicity Is Not a Bad Thing -- Long-Term Drugs Require Long-Term Evaluation -- Doses are Empirical -- “Yes-No” Drugs -- You Do Not Know Until You Try -- Monitoring Is No Substitute for Intelligence -- Afterword -- Appendices -- References. 
650 0 |a Pharmacology. 
650 0 |a Psychiatry. 
650 1 4 |a Pharmacology/Toxicology. 
650 2 4 |a Psychiatry. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
856 4 0 |u https://doi.org/10.1007/978-1-4613-9036-7